Study of SAR439859 Versus Letrozole in ER Positive, HER2 Negative Pre-operative Post-menopausal Primary Breast Cancer
Condition: Breast Cancer Interventions: Drug: SAR439859; Drug: letrozole Sponsor: Sanofi Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials